April McGriff
Family · Houston, TXNPI 1598125932
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,084 of the $2,352 with a category attached, or 88.6%. It is spread thinly across 23 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,300, more than ten times the $25 reported in 2021.
Across 78 payments — averaging $30.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$275
- Bristol Myers Squibb$252
- Pfizer$244
- Karyopharm Therapeutics Inc.$204
- Johnson & Johnson$197
- Janssen Scientific Affairs, LLC$167
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,08489%
- Education$26811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 5 | $275 |
| Bristol Myers Squibb | 9 | $252 |
| Pfizer | 12 | $244 |
| Karyopharm Therapeutics Inc. | 8 | $204 |
| Johnson & Johnson | 7 | $197 |
| Janssen Scientific Affairs, LLC | 6 | $167 |
| Teva Pharmaceuticals USA, Inc. | 1 | $133 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Sobi, Inc | 2 | $98 |
| BTG International Inc. | 5 | $97 |
| ADC Therapeutics America, Inc. | 3 | $87 |
| Lilly USA, LLC | 3 | $84 |
| Lundbeck LLC | 3 | $60 |
| Amgen | 2 | $50 |
| AstraZeneca | 2 | $47 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Merz Pharmaceuticals, LLC | 1 | $37 |
| Sanofi | 1 | $31 |
| AbbVie | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Morphosys, US Inc. | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$133
- ZAVZPRET$125
- REXULTI$125
How this compares
$2,352 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.